Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib plus cisplatin-based chemoradiation for locoregional nasopharyngeal carcinoma
ACTRN12608000449336Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jan 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in nasopharyngeal carcinoma (NPC) comparing Celecoxib arm with Placebo control arm (2 arms). Primary endpoint: Clinical response rate. Started Jan 2008; status: completed.
02
Drugs
celecoxib
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on ACTRN12608000449336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000449336.